Literature DB >> 10496806

Treatment options for chronic hepatitis. Antivirals look promising.

A J Zuckerman, D Lavanchy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10496806      PMCID： PMC1116648          DOI： 10.1136/bmj.319.7213.799

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  A pill a day, or two, for hepatitis B?

Authors:  G Dusheiko
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

2.  Interferon-alpha2b therapy is efficacious in Asian-Americans with chronic hepatitis B infection: a prospective controlled trial.

Authors:  P Martin; H W Hann; S Westerberg; S J Muñoz; R Rubin; W C Maddrey
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.

Authors:  M Melegari; P P Scaglioni; J R Wands
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

4.  A controlled trial of interferon with or without prednisone priming for chronic hepatitis B.

Authors:  A S Lok; P C Wu; C L Lai; J Y Lau; E K Leung; L S Wong; O C Ma; I J Lauder; C P Ng; H T Chung
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

5.  Lamivudine treatment of chronic hepatitis B.

Authors: 
Journal:  Rev Med Virol       Date:  1998-07       Impact factor: 6.989

6.  Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

Authors:  R Perrillo; J Rakela; J Dienstag; G Levy; P Martin; T Wright; S Caldwell; E Schiff; R Gish; J P Villeneuve; G Farr; G Anschuetz; L Crowther; N Brown
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

7.  Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.

Authors:  L Grellier; D Mutimer; M Ahmed; D Brown; A K Burroughs; K Rolles; P McMaster; P Beranek; F Kennedy; H Kibbler; P McPhillips; E Elias; G Dusheiko
Journal:  Lancet       Date:  1996-11-02       Impact factor: 79.321

Review 8.  Lamivudine for hepatitis B in clinical practice.

Authors:  E R Schiff
Journal:  J Med Virol       Date:  2000-07       Impact factor: 2.327

9.  A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Authors:  C L Lai; R N Chien; N W Leung; T T Chang; R Guan; D I Tai; K Y Ng; P C Wu; J C Dent; J Barber; S L Stephenson; D F Gray
Journal:  N Engl J Med       Date:  1998-07-09       Impact factor: 91.245

10.  Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.

Authors:  S K Sarin; R C Guptan; V Thakur; S Malhotra; V Malhotra; K Banerjee; P Khandekar
Journal:  J Hepatol       Date:  1996-04       Impact factor: 25.083
  10 in total
  3 in total

1.  In vitro resistance to interferon of hepatitis B virus with precore mutation.

Authors:  Yan Wang; Lai Wei; Dong Jiang; Xu Cong; Ran Fei; Jiang Xiao; Yu Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

Authors:  M F Sprinzl; H Oberwinkler; H Schaller; U Protzer
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Expression of hepatitis B virus 1.3-fold genome plasmid in an SV40 T-antigen-immortalized mouse hepatic cell line.

Authors:  Xiu-Guang Song; Peng-Fei Bian; Shu-Li Yu; Xiu-Hua Zhao; Wei Xu; Xue-Hui Bu; Xia Li; Li-Xian Ma
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.